Impact of reinfection with SARS-CoV-2 Omicron variants in previously infected hamsters

The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an in vivo, hamster infection model to assess the potenti...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv
Main Authors Shiwa-Sudo, Nozomi, Sakai, Yusuke, Iwata-Yoshikawa, Naoko, Watanabe, Shinji, Yamada, Souichi, Kuroda, Yudai, Yamamoto, Tsukasa, Shirakura, Masayuki, Fujisaki, Seiichiro, Miyazaki, Kaya, Miura, Hideka, Nagata, Shiho, Fukushi, Shuetsu, Maeda, Ken, Hasegawa, Hideki, Suzuki, Tadaki, Nagata, Noriyo
Format Paper
LanguageEnglish
Published Cold Spring Harbor Cold Spring Harbor Laboratory Press 01.09.2022
Cold Spring Harbor Laboratory
Edition1.2
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an in vivo, hamster infection model to assess the potential for individuals previously infected with SARS-CoV-2 to be reinfected with Omicron variant and we also investigated the pathology associated with such infections. Initially, Syrian hamsters were inoculated with a lineage A, B.1.1.7, B.1.351, B.1.617.2 or a subvariant of Omicron, BA.1 strain and then reinfected with the BA.1 strain 5 weeks later. Subsequently, the impact of reinfection with Omicron subvariants (BA.1 and BA.2) in individuals previously infected with the BA.1 strain was examined. Although viral infection and replication were suppressed in both the upper and lower airways, following reinfection, virus-associated RNA was detected in the airways of most hamsters. Viral replication was more strongly suppressed in the lower respiratory tract than in the upper respiratory tract. Consistent amino acid substitutions were observed in the upper respiratory tract of infected hamsters after primary infection with variant BA.1, whereas diverse mutations appeared in hamsters reinfected with the same variant. Histopathology showed no acute pneumonia or disease enhancement in any of the reinfection groups and, in addition, the expression of inflammatory cytokines and chemokines in the airways of reinfected animals was only mildly elevated. These findings are important for understanding the risk of reinfection with new variants of SARS-CoV-2. Competing Interest Statement The authors have declared no competing interest. Footnotes * Add the Supplemental Materials
AbstractList The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an in vivo, hamster infection model to assess the potential for individuals previously infected with SARS-CoV-2 to be reinfected with Omicron variant and we also investigated the pathology associated with such infections. Initially, Syrian hamsters were inoculated with a lineage A, B.1.1.7, B.1.351, B.1.617.2 or a subvariant of Omicron, BA.1 strain and then reinfected with the BA.1 strain 5 weeks later. Subsequently, the impact of reinfection with Omicron subvariants (BA.1 and BA.2) in individuals previously infected with the BA.1 strain was examined. Although viral infection and replication were suppressed in both the upper and lower airways, following reinfection, virus-associated RNA was detected in the airways of most hamsters. Viral replication was more strongly suppressed in the lower respiratory tract than in the upper respiratory tract. Consistent amino acid substitutions were observed in the upper respiratory tract of infected hamsters after primary infection with variant BA.1, whereas diverse mutations appeared in hamsters reinfected with the same variant. Histopathology showed no acute pneumonia or disease enhancement in any of the reinfection groups and, in addition, the expression of inflammatory cytokines and chemokines in the airways of reinfected animals was only mildly elevated. These findings are important for understanding the risk of reinfection with new variants of SARS-CoV-2. Competing Interest Statement The authors have declared no competing interest. Footnotes * Add the Supplemental Materials
The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an in vivo, hamster infection model to assess the potential for individuals previously infected with SARS-CoV-2 to be reinfected with Omicron variant and we also investigated the pathology associated with such infections. Initially, Syrian hamsters were inoculated with a lineage A, B.1.1.7, B.1.351, B.1.617.2 or a subvariant of Omicron, BA.1 strain and then reinfected with the BA.1 strain 5 weeks later. Subsequently, the impact of reinfection with Omicron subvariants (BA.1 and BA.2) in individuals previously infected with the BA.1 strain was examined. Although viral infection and replication were suppressed in both the upper and lower airways, following reinfection, virus-associated RNA was detected in the airways of most hamsters. Viral replication was more strongly suppressed in the lower respiratory tract than in the upper respiratory tract. Consistent amino acid substitutions were observed in the upper respiratory tract of infected hamsters after primary infection with variant BA.1, whereas diverse mutations appeared in hamsters reinfected with the same variant. Histopathology showed no acute pneumonia or disease enhancement in any of the reinfection groups and, in addition, the expression of inflammatory cytokines and chemokines in the airways of reinfected animals was only mildly elevated. These findings are important for understanding the risk of reinfection with new variants of SARS-CoV-2. The emergence of SARS-CoV-2 variants and the widespread use of COVID-19 vaccines has resulted in individual differences in immune status against SARS-CoV-2. A decay in immunity over time and the emergence of variants that partially evade the immune response can also lead to reinfection. In this study, we demonstrated that, in hamsters, immunity acquired following primary infection with previous SARS-CoV-2 variants was effective in preventing the onset of pneumonia after reinfection with the Omicron variant. However, viral infection and multiplication in the upper respiratory tract were still observed after reinfection. We also showed that more diverse nonsynonymous mutations appeared in the upper respiratory tract of reinfected hamsters that had acquired immunity from primary infection. This hamster model reveals the within-host evolution of SARS-CoV-2 and its pathology after reinfection, and provides important information for countermeasures against diversifying SARS-CoV-2 variants.
Author Kuroda, Yudai
Shirakura, Masayuki
Suzuki, Tadaki
Watanabe, Shinji
Miura, Hideka
Yamada, Souichi
Nagata, Noriyo
Yamamoto, Tsukasa
Fujisaki, Seiichiro
Iwata-Yoshikawa, Naoko
Shiwa-Sudo, Nozomi
Sakai, Yusuke
Fukushi, Shuetsu
Nagata, Shiho
Miyazaki, Kaya
Hasegawa, Hideki
Maeda, Ken
Author_xml – sequence: 1
  givenname: Nozomi
  surname: Shiwa-Sudo
  fullname: Shiwa-Sudo, Nozomi
– sequence: 2
  givenname: Yusuke
  surname: Sakai
  fullname: Sakai, Yusuke
– sequence: 3
  givenname: Naoko
  surname: Iwata-Yoshikawa
  fullname: Iwata-Yoshikawa, Naoko
– sequence: 4
  givenname: Shinji
  surname: Watanabe
  fullname: Watanabe, Shinji
– sequence: 5
  givenname: Souichi
  surname: Yamada
  fullname: Yamada, Souichi
– sequence: 6
  givenname: Yudai
  surname: Kuroda
  fullname: Kuroda, Yudai
– sequence: 7
  givenname: Tsukasa
  surname: Yamamoto
  fullname: Yamamoto, Tsukasa
– sequence: 8
  givenname: Masayuki
  surname: Shirakura
  fullname: Shirakura, Masayuki
– sequence: 9
  givenname: Seiichiro
  surname: Fujisaki
  fullname: Fujisaki, Seiichiro
– sequence: 10
  givenname: Kaya
  surname: Miyazaki
  fullname: Miyazaki, Kaya
– sequence: 11
  givenname: Hideka
  surname: Miura
  fullname: Miura, Hideka
– sequence: 12
  givenname: Shiho
  surname: Nagata
  fullname: Nagata, Shiho
– sequence: 13
  givenname: Shuetsu
  surname: Fukushi
  fullname: Fukushi, Shuetsu
– sequence: 14
  givenname: Ken
  surname: Maeda
  fullname: Maeda, Ken
– sequence: 15
  givenname: Hideki
  surname: Hasegawa
  fullname: Hasegawa, Hideki
– sequence: 16
  givenname: Tadaki
  surname: Suzuki
  fullname: Suzuki, Tadaki
– sequence: 17
  givenname: Noriyo
  surname: Nagata
  fullname: Nagata, Noriyo
BookMark eNpNUFFLwzAYDDLBOfcDfAv44kvrl7RJ08cxdA4GA6d7LUmasow1qUk33b93Uh98uuO4O467RSPnnUHonkBKCJAnCpSmINIMUgas5PwKjSkvaSIosNE_foOmMe4BgJacZEU-Rttl20ndY9_gYKxrjO6td_jL9ju8mb1tkrnfJhSvW6vDRT_JYKXrI7YOd8GcrD_GwxkPQVPjnWxjb0K8Q9eNPEQz_cMJ-nh5fp-_Jqv1YjmfrRJFIOdJoQootC5zzUBqUWsgtWhyTqhSRmhe57JQmglRU5MZriVRhjFtTJkxqRhkE_Q49Crrw7c9VV2wrQzn6veSCkSVQTVccrE-DNYu-M-jiX2198fgLusqWoAQBWN5nv0A6W1iyw
ContentType Paper
Copyright 2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022, Posted by Cold Spring Harbor Laboratory
Copyright_xml – notice: 2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022, Posted by Cold Spring Harbor Laboratory
DBID 8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
FX.
DOI 10.1101/2022.08.30.505966
DatabaseName ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
Coronavirus Research Database
ProQuest Central
ProQuest Central Student
SciTech Premium Collection
ProQuest Biological Science Collection
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
bioRxiv
DatabaseTitle Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
DatabaseTitleList Publicly Available Content Database

Database_xml – sequence: 1
  dbid: FX.
  name: bioRxiv
  url: https://www.biorxiv.org/
  sourceTypes: Open Access Repository
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2692-8205
Edition 1.2
ExternalDocumentID 2022.08.30.505966v2
Genre Working Paper/Pre-Print
GroupedDBID 8FE
8FH
ABUWG
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
GNUQQ
HCIFZ
LK8
M7P
NQS
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PROAC
RHI
FX.
ID FETCH-LOGICAL-b1046-7b707cc94c50ac8dc01d8f4612bbe8c6d4a7bc588d2e3e6ca1be55cee935ab503
IEDL.DBID BENPR
ISSN 2692-8205
IngestDate Tue Jan 07 18:51:59 EST 2025
Fri Jul 25 09:20:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
License This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b1046-7b707cc94c50ac8dc01d8f4612bbe8c6d4a7bc588d2e3e6ca1be55cee935ab503
Notes SourceType-Working Papers-1
ObjectType-Working Paper/Pre-Print-1
content type line 50
Competing Interest Statement: The authors have declared no competing interest.
ORCID 0000-0001-9147-1438
0000-0002-3820-9542
OpenAccessLink https://www.proquest.com/docview/2708875544?pq-origsite=%requestingapplication%
PQID 2708875544
PQPubID 2050091
PageCount 50
ParticipantIDs biorxiv_primary_2022_08_30_505966
proquest_journals_2708875544
PublicationCentury 2000
PublicationDate 20220901
PublicationDateYYYYMMDD 2022-09-01
PublicationDate_xml – month: 09
  year: 2022
  text: 20220901
  day: 01
PublicationDecade 2020
PublicationPlace Cold Spring Harbor
PublicationPlace_xml – name: Cold Spring Harbor
PublicationTitle bioRxiv
PublicationYear 2022
Publisher Cold Spring Harbor Laboratory Press
Cold Spring Harbor Laboratory
Publisher_xml – name: Cold Spring Harbor Laboratory Press
– name: Cold Spring Harbor Laboratory
References Pannone, Caponio, De Stefano, Ramunno, Meccariello, Agostinone, Pedicillo, Troiano, Zhurakivska, Cassano, Bizzoca, Papagerakis, Buonaguro, Advani, Muzio (2022.08.30.505966v2.21) 2021; 16
Bourgonje, Abdulle, Timens, Hillebrands, Navis, Gordijn, Bolling, Dijkstra, Voors, Osterhaus, van der Voort, Mulder, van Goor (2022.08.30.505966v2.46) 2020; 251
Hachmann, Miller, Collier, Ventura, Yu, Rowe, Bondzie, Powers, Surve, Hall, Barouch (2022.08.30.505966v2.28) 2022; 387
Iwata-Yoshikawa, Shiwa, Sekizuka, Sano, Ainai, Hemmi, Kataoka, Kuroda, Hasegawa, Suzuki, Nagata (2022.08.30.505966v2.52) 2022; 8
(2022.08.30.505966v2.2) 2021
Zivcec, Safronetz, Haddock, Feldmann, Ebihara (2022.08.30.505966v2.56) 2011; 368
Wang, Sewatanon, Memoli, Wrammert, Bournazos, Bhaumik, Pinsky, Chokephaibulkit, Onlamoon, Pattanapanyasat, Taubenberger, Ahmed, Ravetch (2022.08.30.505966v2.43) 2017; 355
Polak, Van Gool, Cohen, von der Thüsen, van Paassen (2022.08.30.505966v2.20) 2020; 33
2022.08.30.505966v2.1
Halfmann, Kuroda, Armbrust, Accola, Valdez, Kowalski-Dobson, Rehrauer, Gordon, Kawaoka (2022.08.30.505966v2.19) 2022; 38
Cromer, Juno, Khoury, Reynaldi, Wheatley, Kent, Davenport (2022.08.30.505966v2.11) 2021; 21
Mykytyn, Rissmann, Kok, Rosu, Schipper, Breugem, van den Doel, Chandler, Bestebroer, de Wit, van Royen, Molenkamp, Oude Munnink, de Vries, GeurtsvanKessel, Smith, Koopmans, Rockx, Lamers, Fouchier, Haagmans (2022.08.30.505966v2.30) 2022
Smid, Berec, Pribylova, Majek, Pavlik, Jarkovsky, Weiner, Barusova, Trnka (2022.08.30.505966v2.50) 2022
Liu, Soh, Kishikawa, Hirose, Nakayama, Li, Sasai, Suzuki, Tada, Arakawa, Matsuoka, Akamatsu, Matsuda, Ono, Torii, Kishida, Jin, Nakai, Arase, Nakagawa, Matsumoto, Nakazaki, Shindo, Kohyama, Tomii, Ohmura, Ohshima, Okamoto, Yamamoto, Nakagami, Matsuura, Nakagawa, Kato, Okada, Standley, Shioda, Arase (2022.08.30.505966v2.42) 2021; 184
Fall, Eldesouki, Sachithanandham, Morris, Norton, Gaston, Forman, Abdullah, Gallagher, Li, Swanson, Pekosz, Klein, Mostafa (2022.08.30.505966v2.10) 2022; 79
Itokawa, Sekizuka, Hashino, Tanaka, Kuroda (2022.08.30.505966v2.58) 2020; 15
Pulliam, Schalkwyk, Govender, Gottberg, Cohen, Groome, Dushoff, Mlisana, Moultrie (2022.08.30.505966v2.6) 2022; 376
Rosenke, Meade-White, Letko, Clancy, Hansen, Liu, Okumura, Tang-Huau, Li, Saturday, Feldmann, Scott, Wang, Munster, Jarvis, Feldmann (2022.08.30.505966v2.13) 2020; 9
Wilhelm, Widera, Grikscheit, Toptan, Schenk, Pallas, Metzler, Kohmer, Hoehl, Marschalek, Herrmann, Helfritz, Wolf, Goetsch, Ciesek (2022.08.30.505966v2.24) 2022; 82
Quick (2022.08.30.505966v2.57) 2020
Sun, Wang, Tan, Dan, Lu, Zhang, Xu, Tan, Xiang, Zhou, He, Wan, Zhang, Chen, Tan, Deng (2022.08.30.505966v2.34) 2021; 9
Altarawneh, Chemaitelly, Hasan, Ayoub, Qassim, AlMukdad, Coyle, Yassine, Al-Khatib, Benslimane, Al-Kanaani, Al-Kuwari, Jeremijenko, Kaleeckal, Latif, Shaik, Abdul-Rahim, Nasrallah, Al-Kuwari, Butt, Al-Romaihi, Al-Thani, Al-Khal, Bertollini, Tang, Abu-Raddad (2022.08.30.505966v2.48) 2022; 386
Boyton, Altmann (2022.08.30.505966v2.32) 2021; 21
Zhou, Yang, Wang, Hu, Zhang, Zhang, Si, Zhu, Li, Huang (2022.08.30.505966v2.35) 2020; 579
Weiss, Scott (2022.08.30.505966v2.45) 1981; 4
Siggins, Thwaites, Openshaw (2022.08.30.505966v2.33) 2021; 29
Viana, Moyo, Amoako, Tegally, Scheepers, Althaus, Anyaneji, Bester, Boni, Chand, Choga, Colquhoun, Davids, Deforche, Doolabh, du Plessis, Engelbrecht, Everatt, Giandhari, Giovanetti, Hardie, Hill, Hsiao, Iranzadeh, Ismail, Joseph, Joseph, Koopile, Kosakovsky Pond, Kraemer, Kuate-Lere, Laguda-Akingba, Lesetedi-Mafoko, Lessells, Lockman, Lucaci, Maharaj, Mahlangu, Maponga, Mahlakwane, Makatini, Marais, Maruapula, Masupu, Matshaba, Mayaphi, Mbhele, Mbulawa, Mendes, Mlisana (2022.08.30.505966v2.3) 2022; 603
Nunez, Lien, Selvaraj, Stauft, Liu, Starost, Wang (2022.08.30.505966v2.16) 2021
Shrestha, Foster, Rawlinson, Tedla, Bull (2022.08.30.505966v2.27) 2022
Madhi, Kwatra, Myers, Jassat, Dhar, Mukendi, Nana, Blumberg, Welch, Ngorima-Mabhena, Mutevedzi (2022.08.30.505966v2.9) 2022; 386
Dhakal, Ruiz-Bedoya, Zhou, Creisher, Villano, Littlefield, Ruelas Castillo, Marinho, Jedlicka, Ordonez, Bahr, Majewska, Betenbaugh, Flavahan, Mueller, Looney, Quijada, Mota, Beck, Brockhurst, Braxton, Castell, Stover, D’Alessio, Metcalf Pate, Karakousis, Mankowski, Pekosz, Jain, Klein, Johns Hopkins (2022.08.30.505966v2.31) 2021; 12
Rothberg, Kim, Shrestha, Kojima, Tereshchenko (2022.08.30.505966v2.49) 2022
Cao, Wang, Jian, Xiao, Song, Yisimayi, Huang, Li, Wang, An, Wang, Wang, Niu, Yang, Liang, Sun, Li, Yu, Cui, Liu, Yang, Du, Zhang, Hao, Shao, Jin, Wang, Xiao, Wang, Xie (2022.08.30.505966v2.23) 2022; 602
Chan, Zhang, Yuan, Poon, Chan, Lee, Chan, Fan, Tsoi, Wen, Liang, Cao, Chen, Tang, Luo, Cai, Kok, Chu, Chan, Sridhar, Chen, Chen, To, Yuen (2022.08.30.505966v2.14) 2020
Wu, Zhao, Yu, Chen, Wang, Song, Hu, Tao, Tian, Pei, Yuan, Zhang, Dai, Liu, Wang, Zheng, Xu, Holmes, Zhang (2022.08.30.505966v2.39) 2020; 579
Abdelnabi, Boudewijns, Foo, Seldeslachts, Sanchez-Felipe, Zhang, Delang, Maes, Kaptein, Weynand, Vande Velde, Neyts, Dallmeier (2022.08.30.505966v2.17) 2021; 68
Matsuyama, Nao, Shirato, Kawase, Saito, Takayama, Nagata, Sekizuka, Katoh, Kato, Sakata, Tahara, Kutsuna, Ohmagari, Kuroda, Suzuki, Kageyama, Takeda (2022.08.30.505966v2.53) 2020; 117
Karim, Karim (2022.08.30.505966v2.4) 2021; 398
Rodrigues, de Castro, de Albuquerque, Mattaraia, Santoro (2022.08.30.505966v2.55) 2017; 12
Oliviero, de Castro, Coperchini, Chiovato, Rotondi (2022.08.30.505966v2.51) 2021; 27
Halfmann, Iida, Iwatsuki-Horimoto, Maemura, Kiso, Scheaffer, Darling, Joshi, Loeber, Singh, Foster, Ying, Case, Chong, Whitener, Moliva, Floyd, Ujie, Nakajima, Ito, Wright, Uraki, Warang, Gagne, Li, Sakai-Tagawa, Liu, Larson, Osorio, Hernandez-Ortiz, Henry, Ciouderis, Florek, Patel, Odle, Wong, Bateman, Wang, Edara, Chong, Franks, Jeevan, Fabrizio, DeBeauchamp, Kercher, Seiler, Gonzalez-Reiche, Sordillo, Chang, van Bakel (2022.08.30.505966v2.7) 2022
Tran, Taira, Ogawa, Misu, Miyazawa, Kitao (2022.08.30.505966v2.36) 2022; 12
Imai, Iwatsuki-Horimoto, Hatta, Loeber, Halfmann, Nakajima, Watanabe, Ujie, Takahashi, Ito, Yamada, Fan, Chiba, Kuroda, Guan, Takada, Armbrust, Balogh, Furusawa, Okuda, Ueki, Yasuhara, Sakai-Tagawa, Lopes, Kiso, Yamayoshi, Kinoshita, Ohmagari, Hattori, Takeda, Mitsuya, Krammer, Suzuki, Kawaoka (2022.08.30.505966v2.15) 2020; 117
Cameroni, Bowen, Rosen, Saliba, Zepeda, Culap, Pinto, VanBlargan, De Marco, di Iulio, Zatta, Kaiser, Noack, Farhat, Czudnochowski, Havenar-Daughton, Sprouse, Dillen, Powell, Chen, Maher, Yin, Sun, Soriaga, Bassi, Silacci-Fregni, Gustafsson, Franko, Logue, Iqbal, Mazzitelli, Geffner, Grifantini, Chu, Gori, Riva, Giannini, Ceschi, Ferrari, Cippa, Franzetti-Pellanda, Garzoni, Halfmann, Kawaoka, Hebner, Purcell, Piccoli, Pizzuto, Walls, Diamond (2022.08.30.505966v2.22) 2022; 602
Li, Hou, Ma, Wang, Wang, Yu, Chang, Wang, Jin, Wang, Wang, Zhao, Zhao, Xu, Ma, Gao, He (2022.08.30.505966v2.40) 2022; 19
Wolter, Jassat, Walaza, Welch, Moultrie, Groome, Amoako, Everatt, Bhiman, Scheepers, Tebeila, Chiwandire, du Plessis, Govender, Ismail, Glass, Mlisana, Stevens, Treurnicht, Makatini, Hsiao, Parboosing, Wadula, Hussey, Davies, Boulle, von Gottberg, Cohen (2022.08.30.505966v2.5) 2022; 399
Wong, Perlman (2022.08.30.505966v2.12) 2022; 22
Itokawa, Sekizuka, Hashino, Tanaka, Eto, Someno, Kuroda (2022.08.30.505966v2.59) 2021
Andeweg, de Gier, Eggink, van den Ende, van Maarseveen, Ali, Vlaemynck, Schepers, Hahne, Reusken, de Melker, van den Hof, Knol (2022.08.30.505966v2.26) 2022; 13
Pastorio, Zech, Noettger, Jung, Jacob, Sanderson, Sparrer, Kirchhoff (2022.08.30.505966v2.25) 2022
Yuen, Lam, Wong, Mak, Wang, Chu, Cai, Jin, To, Chan, Yuen, Kok (2022.08.30.505966v2.38) 2020; 9
Yamada, Fukushi, Kinoshita, Ohnishi, Suzuki, Fujimoto, Saijo, Maeda (2022.08.30.505966v2.54) 2021; 8
Hansen, Meade-White, Clancy, Rosenke, Okumura, Hawman, Feldmann, Kaza, Jarvis, Rosenke, Feldmann (2022.08.30.505966v2.18) 2022; 38
Kindler, Gil-Cruz, Spanier, Li, Wilhelm, Rabouw, Zust, Hwang, V’Kovski, Stalder, Marti, Habjan, Cervantes-Barragan, Elliot, Karl, Gaughan, van Kuppeveld, Silverman, Keller, Ludewig, Bergmann, Ziebuhr, Weiss, Kalinke, Thiel (2022.08.30.505966v2.37) 2017; 13
Vennema, de Groot, Harbour, Dalderup, Gruffydd-Jones, Horzinek, Spaan (2022.08.30.505966v2.44) 1990; 64
Munoz-Fontela, Dowling, Funnell, Gsell, Riveros-Balta, Albrecht, Andersen, Baric, Carroll, Cavaleri, Qin, Crozier, Dallmeier, de Waal, de Wit, Delang, Dohm, Duprex, Falzarano, Finch, Frieman, Graham, Gralinski, Guilfoyle, Haagmans, Hamilton, Hartman, Herfst, Kaptein, Klimstra, Knezevic, Krause, Kuhn, Le Grand, Lewis, Liu, Maisonnasse, McElroy, Munster, Oreshkova, Rasmussen, Rocha-Pereira, Rockx, Rodriguez, Rogers, Salguero, Schotsaert, Stittelaar, Thibaut, Tseng (2022.08.30.505966v2.29) 2020; 586
Halstead, Katzelnick (2022.08.30.505966v2.47) 2020; 222
Itokawa, Sasaki (2022.08.30.505966v2.60) 2021
Yang, Lin, Tsai, Chien, Wang, Yang, Chang (2022.08.30.505966v2.41) 2021; 84
Iuliano, Brunkard, Boehmer, Peterson, Adjei, Binder, Cobb, Graff, Hidalgo, Panaggio, Rainey, Rao, Soetebier, Wacaster, Ai, Gupta, Molinari, Ritchey (2022.08.30.505966v2.8) 2022; 71
References_xml – volume: 9
  start-page: 1418
  year: 2020
  end-page: 1428
  ident: 2022.08.30.505966v2.38
  article-title: SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
  publication-title: Emerg Microbes Infect
– ident: 2022.08.30.505966v2.1
  publication-title: WHO coronavirus disease (COVID-19) dashboard
– volume: 603
  start-page: 679
  year: 2022
  end-page: 686
  ident: 2022.08.30.505966v2.3
  article-title: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
  publication-title: Nature
– volume: 9
  start-page: 2673
  year: 2020
  end-page: 2684
  ident: 2022.08.30.505966v2.13
  article-title: Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
  publication-title: Emerging Microbes & Infections
– volume: 8
  start-page: eabh3827
  year: 2022
  ident: 2022.08.30.505966v2.52
  article-title: A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection
  publication-title: Sci Adv
– volume: 117
  start-page: 7001
  year: 2020
  end-page: 7003
  ident: 2022.08.30.505966v2.53
  article-title: Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
  publication-title: Proc Natl Acad Sci U S A
– year: 2021
  ident: 2022.08.30.505966v2.59
  article-title: nCoV-2019 sequencing protocol for illumina., on protocols.io
– year: 2022
  ident: 2022.08.30.505966v2.49
  article-title: Protection Against the Omicron Variant Offered by Previous SARS-CoV-2 Infection: A Retrospective Cohort Study
  publication-title: Clin Infect Dis.
– volume: 13
  start-page: 4738
  year: 2022
  ident: 2022.08.30.505966v2.26
  article-title: Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
  publication-title: Nat Commun
– volume: 71
  start-page: 146
  year: 2022
  end-page: 152
  ident: 2022.08.30.505966v2.8
  article-title: Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022
  publication-title: MMWR Morb Mortal Wkly Rep
– volume: 12
  start-page: e0097421
  year: 2021
  ident: 2022.08.30.505966v2.31
  article-title: Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model
  publication-title: mBio
– year: 2022
  ident: 2022.08.30.505966v2.25
  article-title: Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
  publication-title: Cell Host Microbe
– volume: 386
  start-page: 1314
  year: 2022
  end-page: 1326
  ident: 2022.08.30.505966v2.9
  article-title: Population Immunity and Covid-19 Severity with Omicron Variant in South Africa
  publication-title: New England Journal of Medicine
– volume: 79
  start-page: 104008
  year: 2022
  ident: 2022.08.30.505966v2.10
  article-title: The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads
  publication-title: eBioMedicine
– volume: 22
  start-page: 47
  year: 2022
  end-page: 56
  ident: 2022.08.30.505966v2.12
  article-title: Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
  publication-title: Nature Reviews Immunology
– volume: 117
  start-page: 16587
  year: 2020
  end-page: 16595
  ident: 2022.08.30.505966v2.15
  article-title: Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
  publication-title: Proc Natl Acad Sci U S A
– year: 2020
  ident: 2022.08.30.505966v2.57
  article-title: nCoV-2019 sequencing protocol v3 (LoCost), on Version created by Josh Quick
– volume: 27
  start-page: 214
  year: 2021
  end-page: 221
  ident: 2022.08.30.505966v2.51
  article-title: COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
  publication-title: Neuroscientist
– start-page: eabq4450
  year: 2022
  ident: 2022.08.30.505966v2.30
  article-title: Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
  publication-title: Sci Immunol
– volume: 386
  start-page: 1288
  year: 2022
  end-page: 1290
  ident: 2022.08.30.505966v2.48
  article-title: Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
  publication-title: N Engl J Med
– volume: 64
  start-page: 1407
  year: 1990
  end-page: 1409
  ident: 2022.08.30.505966v2.44
  article-title: Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization
  publication-title: J Virol
– volume: 33
  start-page: 2128
  year: 2020
  end-page: 2138
  ident: 2022.08.30.505966v2.20
  article-title: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression
  publication-title: Modern Pathology
– start-page: e2381
  year: 2022
  ident: 2022.08.30.505966v2.27
  article-title: Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
  publication-title: Rev Med Virol
– volume: 9
  start-page: e00261
  year: 2021
  end-page: 00221
  ident: 2022.08.30.505966v2.34
  article-title: SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants
  publication-title: Microbiology Spectrum
– volume: 184
  start-page: 3452
  year: 2021
  end-page: 3466 e3418
  ident: 2022.08.30.505966v2.42
  article-title: An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
  publication-title: Cell
– volume: 21
  start-page: 762
  year: 2021
  end-page: 768
  ident: 2022.08.30.505966v2.32
  article-title: The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
  publication-title: Nature Reviews Immunology
– volume: 4
  start-page: 175
  year: 1981
  end-page: 189
  ident: 2022.08.30.505966v2.45
  article-title: Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever
  publication-title: Comp Immunol Microbiol Infect Dis
– volume: 19
  start-page: 67
  year: 2022
  end-page: 78
  ident: 2022.08.30.505966v2.40
  article-title: SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy
  publication-title: Cell Mol Immunol
– volume: 15
  start-page: e0239403
  year: 2020
  ident: 2022.08.30.505966v2.58
  article-title: Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR
  publication-title: PLoS One
– year: 2022
  ident: 2022.08.30.505966v2.50
  article-title: Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2
  publication-title: J Infect Dis.
– volume: 13
  start-page: e1006195
  year: 2017
  ident: 2022.08.30.505966v2.37
  article-title: Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication
  publication-title: PLoS Pathog
– volume: 82
  start-page: 104158
  year: 2022
  ident: 2022.08.30.505966v2.24
  article-title: Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
  publication-title: EBioMedicine
– year: 2021
  ident: 2022.08.30.505966v2.2
  article-title: Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern, on World Health Organization
– start-page: e0050721
  year: 2021
  ident: 2022.08.30.505966v2.16
  article-title: SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection
  publication-title: mSphere
– volume: 399
  start-page: 437
  year: 2022
  end-page: 446
  ident: 2022.08.30.505966v2.5
  article-title: Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
  publication-title: The Lancet
– volume: 12
  start-page: e0177967
  year: 2017
  ident: 2022.08.30.505966v2.55
  article-title: The gingival vein as a minimally traumatic site for multiple blood sampling in guinea pigs and hamsters
  publication-title: PLoS One
– volume: 602
  start-page: 657
  year: 2022
  end-page: 663
  ident: 2022.08.30.505966v2.23
  article-title: Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
  publication-title: Nature
– volume: 38
  year: 2022
  ident: 2022.08.30.505966v2.18
  article-title: SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
  publication-title: Cell Reports
– volume: 355
  start-page: 395
  year: 2017
  end-page: 398
  ident: 2022.08.30.505966v2.43
  article-title: IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity
  publication-title: Science
– volume: 376
  start-page: eabn4947
  year: 2022
  ident: 2022.08.30.505966v2.6
  article-title: Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
  publication-title: Science
– volume: 602
  start-page: 664
  year: 2022
  end-page: 670
  ident: 2022.08.30.505966v2.22
  article-title: Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
  publication-title: Nature
– volume: 222
  start-page: 1946
  year: 2020
  end-page: 1950
  ident: 2022.08.30.505966v2.47
  article-title: COVID-19 Vaccines: Should We Fear ADE?
  publication-title: J Infect Dis
– volume: 398
  start-page: 2126
  year: 2021
  end-page: 2128
  ident: 2022.08.30.505966v2.4
  article-title: Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
  publication-title: The Lancet
– volume: 586
  start-page: 509
  year: 2020
  end-page: 515
  ident: 2022.08.30.505966v2.29
  article-title: Animal models for COVID-19
  publication-title: Nature
– volume: 8
  year: 2021
  ident: 2022.08.30.505966v2.54
  article-title: Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells
  publication-title: BMJ Open Respir Res
– volume: 68
  start-page: 103403
  year: 2021
  ident: 2022.08.30.505966v2.17
  article-title: Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
  publication-title: EBioMedicine
– volume: 29
  start-page: 648
  year: 2021
  end-page: 662
  ident: 2022.08.30.505966v2.33
  article-title: Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
  publication-title: Trends in Microbiology
– year: 2022
  ident: 2022.08.30.505966v2.7
  article-title: SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
  publication-title: Nature
– volume: 387
  start-page: 86
  year: 2022
  end-page: 88
  ident: 2022.08.30.505966v2.28
  article-title: Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
  publication-title: N Engl J Med
– volume: 21
  start-page: 395
  year: 2021
  end-page: 404
  ident: 2022.08.30.505966v2.11
  article-title: Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
  publication-title: Nature Reviews Immunology
– year: 2020
  ident: 2022.08.30.505966v2.14
  article-title: Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
  publication-title: Clin Infect Dis.
– volume: 84
  start-page: 478
  year: 2021
  end-page: 484
  ident: 2022.08.30.505966v2.41
  article-title: Pandemic analysis of infection and death correlated with genomic open reading frame 10 mutation in severe acute respiratory syndrome coronavirus 2 victims
  publication-title: J Chin Med Assoc
– volume: 16
  start-page: 34
  year: 2021
  ident: 2022.08.30.505966v2.21
  article-title: Lung histopathological findings in COVID-19 disease – a systematic review
  publication-title: Infectious Agents and Cancer
– volume: 579
  start-page: 270
  year: 2020
  end-page: 273
  ident: 2022.08.30.505966v2.35
  article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin
  publication-title: nature
– volume: 368
  start-page: 24
  year: 2011
  end-page: 35
  ident: 2022.08.30.505966v2.56
  article-title: Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus)
  publication-title: J Immunol Methods
– volume: 251
  start-page: 228
  year: 2020
  end-page: 248
  ident: 2022.08.30.505966v2.46
  article-title: Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)
  publication-title: J Pathol
– volume: 579
  start-page: 265
  year: 2020
  end-page: 269
  ident: 2022.08.30.505966v2.39
  article-title: A new coronavirus associated with human respiratory disease in China
  publication-title: Nature
– volume: 12
  start-page: 3860
  year: 2022
  ident: 2022.08.30.505966v2.36
  article-title: Inhibition of the hexamerization of SARS-CoV-2 endoribonuclease and modeling of RNA structures bound to the hexamer
  publication-title: Sci Rep
– year: 2021
  ident: 2022.08.30.505966v2.60
  article-title: Alt_nCov2019_primers_v0.11, on github.com
– volume: 38
  year: 2022
  ident: 2022.08.30.505966v2.19
  article-title: Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model
  publication-title: Cell Reports
SSID ssj0002961374
Score 1.6666367
SecondaryResourceType preprint
Snippet The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further...
SourceID biorxiv
proquest
SourceType Open Access Repository
Aggregation Database
SubjectTerms Amino acids
Chemokines
Cytokines
Infections
Inflammation
Microbiology
Mutation
Replication
Respiratory tract diseases
RNA viruses
Severe acute respiratory syndrome coronavirus 2
Viral infections
SummonAdditionalLinks – databaseName: bioRxiv
  dbid: FX.
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LSwMxEA7aInjziY8qEbympJtkkz1KsVTBB9aW3pa8Fgt2t2xrsf_eTHcrgh68LmQXviQz8818O4PQteSGiSwTJDGeEh5ZS4wVjCgnbaSdzZyDPOTDY9wf8vuxGP8Y9QWySjMpys_Jcl3HB8F2sL7V5aYd4OoR9NxktC1gcky8jZrhSHG4k71x-zu9EiXBT0le1zH_XBki3vpLv-zw2rn09lDzWc98uY-2fH6AdqrpkKtDNLpb_8GIiwyXfiOayjFkTvHg5mVAusWIRPhpCpq6HC8D6wVRC57keAbi3cDp31e4WugdftNTaIowP0LD3u1rt0_qMQjEQAGWSCOptDbhVlBtlbO041TGQ2hijFc2dlzLgK9SLvLMx1Z3jBciOL-ECW0EZceokRe5P0HYhm0JDMzpmLtArKxWhiuWicRkLA5e6hRd1ZCks6rZRQqwpVSljKYVbKeotQErrc_7PI0kWKsQmvCzf7ziHO3Cs0qq1UKNRfnhL4JvX5jL9S5-AWqBn54
  priority: 102
  providerName: Cold Spring Harbor Laboratory Press
Title Impact of reinfection with SARS-CoV-2 Omicron variants in previously infected hamsters
URI https://www.proquest.com/docview/2708875544
https://www.biorxiv.org/content/10.1101/2022.08.30.505966
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEF5si-DNJ9YXK3jduu4j2ZxES4sKamlVegv7ChZsUlst9t-706R6EDyHzWEmM9_OzJf5EDqLheEyyyRJjKdEMGuJsZIT5WLLtLOZc9CHvH-Ibp7F3VAOq4bbrKJVrnLiMlG7wkKP_JzFEA8B_MTl5J2AahRMVysJjRpqhBSsVB01rjsPvf5Pl4UlAa6Wq5hZlITQZ1RWo83wKULhz2CBJ6ctCTI0cAk2o2L6NZr_Sc1LvOluokZPT_x0C635fButl4KRix30crv8qREXGZ76FY8qx9BMxYOr_oC0ixfC8OMYaHY5nodCGHgueJTjCfB5Q5n_tsDlQe_wqx7DnoTZLnrudp7aN6RSRiAGZrIkNjGNrU2ElVRb5Sy9cCoT4bZijFc2ckLHweRKOea5j6y-MF7KgIcJl9pIyvdQPS9yv4-wDZ4KRZnTkXCh1rJaGaF4JhOT8SgAVxOdViZJJ-X-ixTMllKVcpqWZmuio5Wx0ioEZumvww7-f3yINuCNJXHrCNU_pp_-OCD9hzmp3HmCat1h6xtrPagB
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LTxsxEB5BooreCrQqLQ8jlaNb48eu91BVLQ8lBVLES9y2fq0aqeymCY_mT_U34snu0gMSN86WLWs8ns8z83kG4EMqrVBFoWhmA6OSO0etU4JqnzpuvCu8xzjk0SDpncvvl-pyDv61f2GQVtnaxJmh9pXDGPknnuJ9iOAnv4z-UOwahdnVtoVGrRYHYXoXXbbJ5_5uPN8tzvf3znZ6tOkqQC3mM2lqU5Y6l0mnmHHaO7btdSEj0lsbtEu8NGncrtaeBxESZ7ZtUCpiSSaUsYqJuO48dKVIGO9A99ve4PjkIarDswiPs9LPPMmiqeFMNanUqPoYaOBYMFSwjwrb3uCj2w6r8d_h7SMomOHb_ivoHptRGC_CXCiX4EXdoHK6DBf92SdKUhVkHFreVkkweEtOv56c0p3qgnLy4wppfSW5jY438mrIsCQj5A9XN5PfU1JPDJ78MldYl2HyGs6fRWZvoFNWZXgLxEXNiE6gN4n00bdzRlupRaEyW4gkAuUKbDYiyUd1vY0cxZYznQuW12JbgdVWWHlz5Sb5fwV59_TwBiz0zo4O88P-4OA9vMTVa9LYKnSuxzdhLb4yru16c7QEfj63Nt0DCjblXQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LTxRBEK4gBOMNFSKK2iZw7E1vP2Z6DhwMuGFFkPDK3sZ-TdhEZja7gO7f8hdatTPrRQ9eOE-m011d3V89vq4C2M21V6aqDC98ElzLELgPRnEb8yBdDFWMFIc8Oc2OrvTnkRmtwK_lWxiiVfpxM_05fljk8Ymwjbdve7hFn3x1STU3legZ6hyT9ShM3ZvEqiNWHqf5D3TbZvvDQ9zjPSkHny4PjnjXWYB7ymny3OciD6HQwQgXbAyiH22lEe29TzZkUbscp2xtlEmlLLi-T8YgnhTKOG-EwnGfwBrqsqZ2EYNR709cRxYIkLnuEqj_nDKa2t0S_wKABaoNNmDtzE3S9DmspPoFrLdtKecv4Xq4eDrJmopN05KtVTMK2bKLj-cX_KC55pJ9vSUyX80e0N0mNg0b12xCrOHmfvZ9ztofU2Q37paqMcw24epRpLQFq3VTp1fAAuoDun7RZTqiRxec9dqqyhS-UhnC4zZ86ERSTtoqGyWJrRS2VKJsxbYNO0thld1Bm5Uyp2sSbSL9-j-GeA9Pzw4H5Zfh6fEbeEafW7rYDqzeTe_TW7Qv7vy7xYYy-PbYGvQbiVjg-w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+reinfection+with+SARS-CoV-2+Omicron+variants+in+previously+infected+hamsters&rft.jtitle=bioRxiv&rft.au=Shiwa-Sudo%2C+Nozomi&rft.au=Sakai%2C+Yusuke&rft.au=Iwata-Yoshikawa%2C+Naoko&rft.au=Watanabe%2C+Shinji&rft.date=2022-09-01&rft.pub=Cold+Spring+Harbor+Laboratory+Press&rft.issn=2692-8205&rft.eissn=2692-8205&rft_id=info:doi/10.1101%2F2022.08.30.505966
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2692-8205&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2692-8205&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2692-8205&client=summon